Tenet Healthcare (THC) Cost of Revenue (2009 - 2026)

Tenet Healthcare has disclosed Cost of Revenue across 18 years of filings, most recently posting $961.0 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $961.0 million, down 11.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.0 billion (down 13.58% YoY), and the FY2025 annual result was $3.8 billion, down 15.85% from the prior year.
• Cost of Revenue came in at $961.0 million for Q1 2026 at Tenet Healthcare, down from $1.0 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $1.8 billion in Q4 2024 to a low of $811.0 million in Q2 2022.
• The 5-year median for Cost of Revenue is $942.0 million (2022), against an average of $1.0 billion.
• Across the five-year window, Cost of Revenue surged 90.66% in 2024 and plunged 43.1% in 2025, its largest moves.
• Tenet Healthcare's Cost of Revenue stood at $1.0 billion in 2022, then declined by 9.79% to $931.0 million in 2023, then soared by 90.66% to $1.8 billion in 2024, then slumped by 43.1% to $1.0 billion in 2025, then declined by 4.85% to $961.0 million in 2026.
• The last three Cost of Revenue figures came in at $961.0 million (Q1 2026), $1.0 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.